David J. Bearss, PhD
Co-Director, Center for Investigational Therapeutics
Associate Professor, Department of Oncological Sciences
David Bearss, PhD, is co-director of the Center for Investigational Therapeutics at Huntsman Cancer Institute (HCI) and an associate professor for the Department of Oncological Sciences at the University of Utah. He is a member of the Imaging, Diagnostics, and Therapeutics Program and an HCI investigator.
He researches small molecule drug development, genetic model systems in drug discovery, and translational research focused on cancer drug development.
Bearss is an expert in the development of new cancer therapies. He served as chief scientific officer at SuperGen Inc, a drug development company that specializes in the discovery and development of novel cancer therapies. He also served as founder and chief scientific officer at Montigen Pharmaceuticals.
Bearss earned a bachelor's degree from Brigham Young University and a PhD from the University of Texas Health Sciences Center, San Antonio.